MR Spectroscopy and Imaging in Brain Cancers
common.study.values.description
“Clinical Development of MR Spectroscopy and Imaging in Brain Cancers”
The Investigators will examine the disease specificity of 2-hydroxyglutarate in non-glioma brain lesions, and the clinical utility of 2-hydroxyglutarate, glycine and citrate in isocitrate dehydrogenase (IDH) mutated gliomas and IDH wild type gliomas.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Device - 3 Tesla Scanning
Approximately 120 brain tumor patients 50 patients with non-glioma disease, and 5 healthy volunteers will be scanned at either 3 Tesla or 7 Tesla.
Device - 7 Tesla Scanning
Approximately 120 brain tumor patients 50 patients with non-glioma disease, and 5 healthy volunteers will be scanned at either 3 Tesla or 7 Tesla.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
common.study.values.clinical-trial-id
NCT02731521
participant.views.study.view.id
nel61b
